Use access key #2 to skip to page content.
$2.35 0.00 (0.00%)
6/9/2008 4:00 PM

Encysive Pharmaceuticals, Inc. (ENCY.DL)

CAPS Rating:
No stars

A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.

View All Commentary (ENCY.DL)

Recs

0

Avatar tharlow (76.20) Submitted: 8/17/07 10:01 PM : Outperform Start Price: $1.95 ENCY.DL Score: 26.40

European sales will blow away estimates.

Report this Post Replies: 0 | Reply

Featured Broker Partners